Thermo Fisher Scientific Inc. $TMO Shares Sold by Cyndeo Wealth Partners LLC

Cyndeo Wealth Partners LLC cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 57.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,060 shares of the medical research company’s stock after selling 2,806 shares during the period. Cyndeo Wealth Partners LLC’s holdings in Thermo Fisher Scientific were worth $999,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Quotient Wealth Partners LLC boosted its stake in Thermo Fisher Scientific by 6.4% in the third quarter. Quotient Wealth Partners LLC now owns 968 shares of the medical research company’s stock valued at $470,000 after acquiring an additional 58 shares during the period. Abound Wealth Management boosted its position in Thermo Fisher Scientific by 111.4% during the 3rd quarter. Abound Wealth Management now owns 93 shares of the medical research company’s stock valued at $45,000 after purchasing an additional 49 shares during the period. Perpetual Ltd increased its position in Thermo Fisher Scientific by 4.8% in the third quarter. Perpetual Ltd now owns 419,130 shares of the medical research company’s stock worth $203,286,000 after buying an additional 19,193 shares during the period. KMG Fiduciary Partners LLC lifted its stake in Thermo Fisher Scientific by 4.7% in the third quarter. KMG Fiduciary Partners LLC now owns 5,790 shares of the medical research company’s stock valued at $2,808,000 after buying an additional 261 shares during the last quarter. Finally, Signal Advisors Wealth LLC boosted its holdings in shares of Thermo Fisher Scientific by 92.4% during the third quarter. Signal Advisors Wealth LLC now owns 4,429 shares of the medical research company’s stock valued at $2,148,000 after acquiring an additional 2,127 shares during the period. Institutional investors own 89.23% of the company’s stock.

Insider Activity

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 7,250 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $566.10, for a total value of $4,104,225.00. Following the transaction, the chief executive officer owned 113,762 shares in the company, valued at approximately $64,400,668.20. The trade was a 5.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Michel Lagarde sold 22,046 shares of the stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $563.56, for a total value of $12,424,243.76. Following the sale, the chief operating officer owned 84,117 shares of the company’s stock, valued at $47,404,976.52. This trade represents a 20.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 149,271 shares of company stock valued at $86,507,282 in the last ninety days. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on TMO shares. Evercore ISI lifted their price objective on shares of Thermo Fisher Scientific from $525.00 to $590.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Barclays lifted their price target on Thermo Fisher Scientific from $585.00 to $625.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Redburn Partners set a $580.00 price objective on Thermo Fisher Scientific in a report on Wednesday, October 8th. Leerink Partners lifted their target price on Thermo Fisher Scientific from $545.00 to $580.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $616.60.

Thermo Fisher Scientific Stock Up 0.8%

Shares of TMO stock opened at $567.01 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.11 and a current ratio of 1.50. The stock has a market cap of $213.03 billion, a PE ratio of 32.76, a price-to-earnings-growth ratio of 4.21 and a beta of 0.90. The business’s fifty day moving average is $569.01 and its 200-day moving average is $498.06. Thermo Fisher Scientific Inc. has a 1 year low of $385.46 and a 1 year high of $610.97.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share for the quarter, beating the consensus estimate of $5.50 by $0.29. Thermo Fisher Scientific had a return on equity of 16.97% and a net margin of 15.02%.The business had revenue of $11.12 billion during the quarter, compared to analysts’ expectations of $10.90 billion. During the same quarter last year, the business posted $5.28 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. Equities analysts expect that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific announced that its board has approved a share repurchase plan on Thursday, November 6th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the medical research company to purchase up to 2.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

Thermo Fisher Scientific Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $1.72 annualized dividend and a yield of 0.3%. Thermo Fisher Scientific’s dividend payout ratio is currently 9.94%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.